---
figid: PMC9526656__ECAM2022-3498310.005
pmcid: PMC9526656
image_filename: ECAM2022-3498310.005.jpg
figure_link: /pmc/articles/PMC9526656/figure/fig5/
number: Figure 5
figure_title: ''
caption: 'AB-PAS staining results of the therapeutic effect of Jatrorrhizine on UC
  mice. (AB-PAS staining, 100×). (Ctrl: control group; DSS: DSS group; 5-ASA: mesalazine
  group; Jat L: Jatrorrhizine 40 mg/kg dose group; Jat M: Jatrorrhizine 80 mg/kg dose
  group; Jat H: Jatrorrhizine 160 mg/kg dose group).'
article_title: Jatrorrhizine Alleviates DSS-Induced Ulcerative Colitis by Regulating
  the Intestinal Barrier Function and Inhibiting TLR4/MyD88/NF-κB Signaling Pathway.
citation: Shengqi Niu, et al. Evid Based Complement Alternat Med. 2022;2022:3498310.
year: '2022'

doi: 10.1155/2022/3498310
journal_title: 'Evidence-based Complementary and Alternative Medicine : eCAM'
journal_nlm_ta: Evid Based Complement Alternat Med
publisher_name: Hindawi

keywords:
---
